Paul Spence Jr. - 15 Dec 2022 Form 4 Insider Report for OptiNose, Inc. (OPTN)

Role
Chief Commercial Officer
Signature
/s/ Anthony Krick, Attorney-in-Fact
Issuer symbol
OPTN
Transactions as of
15 Dec 2022
Net transactions value
$0
Form type
4
Filing time
15 Dec 2022, 16:16:54 UTC
Next filing
29 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OPTN Stock Option (Right to Buy) Award $0 +500,000 $0.000000 500,000 15 Dec 2022 Common Stock 500,000 $1.75 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable over a four-year period commencing on December 15, 2022. Twenty-five percent (25%) of the option vests and becomes exercisable on December 15, 2023, and the balance vests in equal monthly installments (rounded down to the nearest whole share) over the remaining three years of the four-year period, subject to continued service with the Issuer.